CHAPTER I U.K. GENERAL PROVISIONS

Article 2 U.K. Time frame for inspections

Inspections may take place in any of the following circumstances:

(a)

before, during or after the conduct of a clinical trial;

(b)

as part of the verification of applications for marketing authorisation;

(c)

as a follow-up to the granting of a marketing authorisation.